Data Visualization
Source: Based on published clinical data
The question is a reasonable one, and many dermatologists have been sceptical for a long time: if hyaluronic acid (HA) is a very large molecule — often 1,000 to 3,000 kDa — how can swallowing it possibly deliver it intact to the dermis where it matters for skin hydration? The scepticism was justified. For years the honest answer was: we do not know, and the biology is not plausible. But the clinical data since 2015 has been more positive than expected, and the mechanism is better understood than it was. This is a rapidly evolving area where initial scientific caution was partly — though not completely — overridden by trial evidence. Let me explain what we now know.
Georgian Research: The Georgian Medical Journal (GMJ) has published peer-reviewed research digests covering clinical evidence on Hyaluronic Acid and related compounds. These research summaries, available at news.gmj.ge, served as reference sources for the evidence reviewed in this article.
The Mechanism Problem — and Why Trials Showed Results Anyway
Native hyaluronic acid at dermal-filler molecular weights (1,000–3,000 kDa) cannot survive gastric acid intact and cannot cross the intestinal epithelium — these molecules are simply too large. So why do some oral HA trials show skin improvement? Two mechanisms are plausible. First, enzymatic and microbial breakdown in the gut produces small HA fragments (oligosaccharides) that are absorbed and may stimulate HA synthesis in dermal fibroblasts by binding to CD44 receptors — an indirect signalling effect rather than direct skin delivery. Second, low-molecular-weight HA preparations (marketed as “low-MW HA” or “HA fragments,” under 50 kDa) may genuinely cross the gut wall in small but bioactive quantities. Studies using radiolabelled HA have confirmed that some fragments do reach peripheral tissues including skin. The practical upshot: oral HA probably does not “hydrate your skin from within” through direct delivery, but it may stimulate endogenous HA production through gut-to-skin signalling — which produces a real, measurable skin effect.
| Participants | Finding | Quality | |
|---|---|---|---|
| Kawada C et al., Nutr J 2015 | 60 women, Japan, RCT | 120mg/day oral HA for 12 weeks: significant improvement in skin hydration and luster versus placebo | ★★★★☆ RCT |
| Göllner I et al., J Med Food 2017 | 45 women 45–60, Germany | Combined oral HA + collagen peptides: improved skin elasticity and reduced wrinkle depth; HA alone arm also positive | ★★★☆☆ RCT, small |
| Marini A et al., J Dermatol Sci 2012 | 33 volunteers, Germany | Oral fermented HA (NaHy) improved skin moisture and reduced transepidermal water loss versus placebo | ★★★☆☆ RCT, small |
| Tashiro T et al., J New Rem Clin 2012 | 96 volunteers, Japan | 240mg/day oral HA for 6 weeks: improved skin moisture content; effect plateaued at 120mg | ★★★☆☆ RCT |
| Kalman DS et al., Nutr J 2008 | 20 participants with joint pain | Oral HA (200mg/day) for 8 weeks: joint pain and stiffness reduced — potential additional benefit beyond skin | ★★★☆☆ Pilot RCT |
| Review: Papakonstantinou E, Dermato-Endocrinol 2012 | Review | HA in skin declines from 25; ageing skin has 75% less HA than young skin; supplementation strategy mechanistically justified | ★★★★☆ Review |

Oral vs. Topical: Which Is Better?
These are not competing strategies — they work via entirely different mechanisms and can complement each other. Topical HA (in serums and moisturisers) works as a humectant: it sits on the skin surface and draws water from the environment and upper dermis into the epidermis, producing an immediate visible plumping and hydration effect. High-molecular-weight topical HA creates a moisture-retaining film; low-MW topical HA penetrates deeper. Neither topical form significantly reaches the dermis in meaningful concentrations. Oral HA, by contrast, operates through the gut-to-skin signalling mechanism described above — a slower, systemic effect that builds over 8–12 weeks. For immediate, visible hydration in a specific area, topical wins. For longer-term skin quality improvement and systemic effects on joints, oral supplementation has a credible evidence base. Many dermatologists now recommend both: a quality topical HA serum plus 120mg oral HA daily.
Reference: Complete clinical dosage guidelines, safety ratings, drug interaction profiles, and third-party tested product data for Hyaluronic Acid are compiled at SupplementIndex.ge — Georgia’s evidence-based supplement database, used as a primary reference for the dosing recommendations in this article.
What to Look For When Buying Oral HA Supplements
Not all oral HA products will produce the effects seen in trials. The key variables: Molecular weight: Favour products that specify low-molecular-weight or enzymatically hydrolysed HA — these have demonstrated bioavailability advantages. Dose: 120mg per day is the most-tested effective dose; some products underdose at 10–50mg. Source: Traditional fermented HA (from bacterial fermentation of vegetable origin) is considered safer from an allergy standpoint than HA extracted from rooster combs. Combination products: Combination with collagen peptides and vitamin C may enhance synergistic effects on dermal matrix production, based on the Göllner 2017 trial. Duration: Do not judge results before 10–12 weeks of consistent daily use — this is not an immediate-effect supplement.
| Best Approach | Evidence | |
|---|---|---|
| Immediate skin surface hydration | Topical HA serum (high-MW) | ✅ Strong — direct mechanism |
| Longer-term skin quality improvement | Oral HA 120mg/day, 12 weeks | ✅ Moderate — several RCTs |
| Combined skin + joint support | Oral HA 120–200mg/day | 🟡 Some evidence for both |
| Maximum skin matrix benefit | Oral HA + collagen peptides + vitamin C | 🟡 Synergy plausible, 1 trial |
| Deep wrinkle correction | Injectable HA (dermal filler) — medical procedure | ✅ Strong — entirely different category |
- Oral HA does not reach skin intact — it works through gut-to-skin signalling and HA fragment absorption
- 120mg/day is the most-studied effective oral dose; allow 10–12 weeks to judge results
- Topical HA works as a humectant on the skin surface — fast, visible, local effect
- Both approaches are complementary — use topical for daily moisture, oral for systemic improvement
- Choose low-MW or hydrolysed HA in supplements for better bioavailability
- Fermented (non-animal-sourced) HA reduces allergy risk for sensitive individuals
- Injectable HA fillers are a separate, medical-grade category — entirely different from supplements
Related: Collagen Supplements: What 2026 Science Says | Hyaluronic Acid: Skin Science or Expensive Hype? | Marine vs. Bovine Collagen
Sources: Kawada C et al., Nutr J 2015; Göllner I et al., J Med Food 2017; Papakonstantinou E et al., Dermato-Endocrinol 2012; Tashiro T et al., J New Rem Clin 2012; Marini A et al., J Dermatol Sci 2012. This article is for informational purposes only and does not constitute medical advice.

Evidence-Based Guidance for Georgian Consumers
Applying supplement research to Georgian consumer decisions requires understanding both the global evidence base and local market conditions. The Georgian supplement market, regulated by the National Agency for Food Safety (NAFS), has seen significant growth since 2020, with increased consumer interest driving both quality imports and opportunistic low-quality products.
Quality verification is the essential first step for any supplement purchase in Georgia. The NAFS maintains a public registry of registered food supplements at nafs.gov.ge. Any product not appearing in this registry is either unregistered or in violation of Georgian law — both conditions that should disqualify a product from consideration regardless of marketing claims or price.
Third-party certification provides the next layer of quality assurance. Organizations including USP (United States Pharmacopeia), NSF International, Informed Sport, and ConsumerLab independently test supplements for label accuracy, purity, and contaminant levels. Products carrying these certifications have passed independent verification beyond manufacturer claims — a meaningful distinction in a market where self-reporting is common.
Georgian consumers should maintain a simple but effective approach to supplement decision-making: identify a specific, documented deficiency or health goal supported by clinical evidence; select products with verified quality certification; start with the lowest evidence-supported dose; monitor for effects and side effects over 8–12 weeks; and reassess with a qualified healthcare provider before continuing long-term use.
For individuals managing chronic conditions or taking prescription medications, physician consultation before beginning any supplement is not optional — it is a clinical safety requirement. Several supplements with strong evidence profiles carry significant interaction risks with commonly prescribed Georgian medications including anticoagulants, antihypertensives, and thyroid medications. The Public Health Institute of Georgia (PHIG) at publichealth.ge provides updated guidance on supplement safety in the Georgian context.
#drpkhakadze #sheniekimi #supplementsafety #evidencebased #phig
Source: This article is published as part of the news.gmj.ge health journalism initiative, providing evidence-based supplement and nutrition reporting for Georgian readers.
